A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers. [electronic resource]
Producer: 20141009Description: 766-70 p. digitalISSN:- 1096-8652
- Activin Receptors, Type II -- administration & dosage
- Aged
- Cell Differentiation -- drug effects
- Cohort Studies
- Dose-Response Relationship, Drug
- Double-Blind Method
- Erythroid Precursor Cells -- cytology
- Erythropoiesis -- drug effects
- Female
- Humans
- Injections, Subcutaneous
- Middle Aged
- Postmenopause -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.